COVID-19 therapeutics and clinical information

Updated | 2 Min Read

Find clinical guidance from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), AMA and other health and medical research organizations.

Vaccination recommendations

COVID-19 therapeutics

COVID-19 therapeutics can be used to prevent or treat eligible  patients who have tested positive for COVID-19 and have mild to moderate symptoms. Prevention and early treatment for eligible patients can help improve patient outcomes, reduce stress on health care facilities, and save lives.

FDA emergency use authorization (EUA)

In December 2021, the U.S. Food and Drug Administration (FDA) issued an EUA for Merck’s molnupiravir and Pfizer’s Paxlovid for the treatment of mild-to-moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19. 

Post-COVID conditions (long COVID)

Post-COVID conditions are a wide range of new, returning, or ongoing health problems people can experience four or more weeks after first being infected with the virus that causes COVID-19. Even people who did not have COVID-19 symptoms in the days or weeks after they were infected can have post-COVID conditions.

Multisystem inflammatory syndrome (MIS)

Multisystem inflammatory syndrome (MIS) can affect children (MIS-C) and adults (MIS-A). MIS is a rare but serious condition associated with COVID-19 in which different body parts become inflamed, including the heart, lungs, kidneys, brain, skin, eyes or gastrointestinal organs.

More information is available from the CDC.

Persons under investigation

COVID-19 testing

FEATURED STORIES

Man power walking or jogging, with dumbbells

New changes expand diabetes-prevention for more Medicare patients

| 3 Min Read
Three healthcare workers in discussion

AMA Joy in Medicine points the way to better care

| 5 Min Read
Doctors hold up magnifying glasses over a giant pancreas

Beyond watch and wait: Taking aim at pancreatic cysts

| 7 Min Read
Philip Kuriakose, MD, featured on "Health vs. Hype" AMA podcast

5 things patients should know about microplastics

| 8 Min Read